Apr 11,2018
Livongo gets $105 million funding in Series E
Digital chronic disease management company Livongo has raised $105 million in new Series E funding, mostly from existing investors. General Catalyst and Swedish investment company Kinnevik led the round, with additional participation from existing investors DFJ, Kleiner Perkins Caufield & Byers , Merck Global Health Innovation Fund, Microsoft Ventures, Sapphire Ventures, Zaffre Investments, and 7wire Ventures. The company also announced a partnership with nonprofit health insurance company Cambia Health Solutions.
FUNDING
SERIES E
View Analyst & Ambassador Comments
Go to original news